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Abstract
Problem: Uninsured African Americans are underdiagnosed and often untreated for
depression. Individuals usually do not present to their primary care provider with a
complaint of depressed mood, however, may report symptoms such as decreased energy,
general body aches, digestive concerns, somatic complaints, or older adults' memory or
cognitive problems. The purpose of this quality improvement pilot project was to
examine the results of the implementation of a depression screening (PHQ-9) in a
primary care setting for uninsured adults for detection, diagnosis, and treatment of
depression in African American clients.
Methods: The IOWA model of Evidence-Based Practice guided this pilot project in the
examination of depression screening in a primary care clinic. The retrospective study
utilized a descriptive analysis conducted over three months with a convenience sample of
uninsured African American new clients 18 -65 years old.
Results: The PHQ-9 screening questionnaire was given to 100% (N=24) of new clients
seen over three months. There were 16.6% (n=4) whites and 83.3% (n=20) African
Americans. Of the African American clients 25% (n=5) scored 10 –14 indicating
moderate depression; 5% (n=1) scored six points signaling mild depression; 70% (n=14)
scored zero suggesting none to minimally depressed. Providers reviewed all client’s
results and recommended either treatment, counseling, or medication.
Implications for Practice: Utilization of the PHQ-9 screening questionnaire with
uninsured African American clients in primary care resulted in an increase in the number
of African Americans diagnosed and treated for depression. Incorporating depression
screening with the initial primary care visit can be beneficial.
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Evaluating the Effectiveness of Implementing Depression Screenings
with Uninsured African American Adults
Depression is a common mental disorder and is one of the leading causes of
disability worldwide that can affect anyone, regardless of race, ethnicity, or
socioeconomic status, and affect of 3.8% of the global population (Bailey et al., 2019;
Cobb et al., 2020; Siu et al., 2016; World Health Organization [WHO], 2021). In 2020,
the prevalence of adults aged eighteen or older in the US with one major depressive
episode was 21.0 million adults (National Institute of Mental Health [NIMH], 2022).
Major depressive disorder (MDD), or clinical depression, is interchangeably and,
according to the American Psychiatric Association [APA] (2020), is a common and
potentially severe medical illness. The Diagnostic and Statistical Manual of Mental
Disorders, 5th edition (DSM 5) references this disorder to be associated with features of
sadness, hopelessness, and a loss of interest in activities that one once enjoyed. Little to
no research about the prevalence of depression or the treatment, specifically in African
Americans (AA), is a contributing factor when addressing treatment. However, one study
posits the reason depression is often untreated in AA could be contributed to racism
(Cobb et al., 2020). The limited studies on AA that explored the prevalence of the major
depressive disorder, assessed AA are more likely to have feelings of sadness,
hopelessness, and worthlessness than other ethnicities (Bailey et al., 2019; Center for
Disease Control and Prevention, [CDC], 2021; Cobb et al., 2020). Furthermore, Bailey et
al. (2019) declared providers must be astute to the differences in the presentation of how
AA will present depression compared to whites. Depression is a complex interaction with
biological and psychosocial factors that can make it difficult to recognize. Although
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cultural norms influence the clinical presentation, hopelessness and despair often
associated with depression are part of the disorder that may interfere with compliance and
treatment to a medical regimen (Feldman et al., 2020; WHO, 2021).
In 2019, the AA population in the United States (US) was 38,872,200 or 12.2
percent of the total population (US Census Bureau, 2020). Uninsured AA account for
10.1 % compared to 6.3 % of uninsured whites in the US (US Department of Health and
Human Services Office of Minority Health [USDHHS OMH], 2021) . Uninsured AA in
St. Louis City was 10.5 %, slightly higher than in the US as reported in 2019 the
American Community Survey 1- year (St. Louis City-MO Gov, n.d; US Census Bureau,
2020). The study further emphasized that AA residents were twice as likely to be
uninsured as whites, with 14% AA versus whites at 7%. This lack of insurance creates a
barrier to health and mental health services resulting in AA receiving poorer care or no
care at all (Walker et al, 2015).
The lack of health insurance is the single greatest obstacle to health care, mental
health services, and quality of care and is a major social determinate of health (SDOH)
(King et al., 2016). Often underinsured or uninsured individuals will not seek treatment
for depression; therefore, when an individual seeks medical treatment in a primary care
setting, it is imperative that the providers conduct a physical and mental health
assessment (Meyers et al, 2014).
Studies have confirmed recognizing depression in a primary care setting,
especially in a patient with co-morbid conditions, is difficult (Ferenchick et al., 2019;
Hooker et al., 2019; Park & Zarate, 2019; Richardson & Brahmbhatt, 2021). Patients
usually do not come in with a complaint of depressed mood, but instead will report
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symptoms, such as decreased energy, general body aches, digestive concerns, somatic
complaints, or in the case of older adults' memory or cognitive problems (Haftgoli et al.,
2010; Riley & Daniel, 2020). Individuals who are depressed are at an increased risk for
suicide, and there appears to be a link to medical outcomes and even deaths when it cooccurs with co-morbid diseases (NIMH, 2021).
Bamgbade et al. (2020) highlighted that AA lives with significantly more
persistent, chronic, and disabling depression compared to whites, even though whites
have a much higher lifetime prevalence of depression. The study further reported that
81% of AA young adults do not seek treatment for depression compared with 66% of
their white counterparts.
This quality improvement (QI) pilot project was conducted at a clinic where
approximately 92% of the clients served are AA,18 through 72 years old, low income, all
are uninsured, and not routinely screened for depression during their primary care visit.
The US Preventive Services Task Force (USPSTF) advocates during a primary care visit
or checkup, screening for depression should be completed regularly, using a screening
tool such as the Patient Health Questionnaire-9, (PHQ-(9), which can indicate early
identification, diagnosis, and need for follow up (Siu et al., 2016).
The Iowa Model of Evidence-Based Practice (EBP) framework guided this
project. This EBP QI pilot project examined the effects of the PHQ-9 on diagnosing and
initiating treatment for depression. The aim was to increase the number of uninsured AA
adults who were screened for depression over three months. The primary outcome
measures of interest were the results of the PHQ-9. The secondary outcome measure was
to identify if the clients received a further evaluation for a diagnosis of depression, and
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treatment initiated. The question for the study was: In AA adults 18 to 65 years old,
newly admitted to the clinic, what is the effect of screening for depression using the
PHQ-9 on the diagnosis and treatment for depression over three months.
Review of the Literature
A review of the literature was conducted using Cochrane, CINAHL, PubMed, and
PsychInfo databases. The key terms and phrases used were depression, AA depression,
primary care, Blacks and depression, and AA mental health. Boolean operators included
"AA adults" AND "depression" OR "screenings" AND "treatment" OR "Blacks" AND
"depression" OR "AA" AND "mental health" OR "treatment," resulting in 236 articles.
The inclusion criteria for this study were articles published from 2016 – 2021, peered
reviewed, written in the English language, and studies with participants 18-65 years old
or older that focused on AA and depression screenings and treatment. The exclusion
criteria were articles published before 2016, not written in the English language,
participants less than 18 years of age, and did not study depression screenings and
treatment in AA. When refining the search using the inclusion and exclusion criteria, ten
articles were identified for final review. The level of evidence of the articles selected
consisted of two systematic reviews, one meta-analysis, four cross-sectional studies, and
three case-control.
Depression is rapidly increasing in society and is less likely to be addressed in AA
with their primary provider due to discrimination. Cobb et al. (2020) study suggested
structured racism is a significant factor in why depression is often untreated in AA.
Therefore, it is critical for providers to acknowledge race and racism in health care and
disparities that exist in all aspects of depression as well. Providers must be aware the
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presentation of depression among AA is different when compared with whites (Bailey et
al., 2019). Additionally, the severity of the depression often leads to an overall degree of
functional impairment and the type of treatment available to AA was also different. Lowincome, uninsured patients already have many obstacles to adequate self-care. When
these patients present to their primary care providers with co-existing depression and
other medical conditions, the priority for treatment is the medical condition.
A mental health screening should be included in an annual physical and regular
screening visit with the primary care provider (Siu et al., 2016). Understanding a person's
health history and self-care practices when living with a chronic health condition can be
an avenue to begin discussions about depression (Barnes et al., 2018). Equally important
is having the awareness when addressing screening, diagnosing, and treating uninsured
AA adults, that age, gender, educational attainment, financial situation, living
arrangements, insurance type, and socio-economic status are significant variables of
SDOH that significantly affect health outcomes (Cobb et al., 2020; King et al., 2016).
Additional factors to consider, AA are at risk for not receiving a diagnosis of depression
by primary care providers or open to receiving treatment for depression (Cobb et al.,
2020).
Primary care providers must understand it is vitally important to include screening
and assessment of mental health in the primary setting and initiate the conversation about
depression since AA does not initiate conversations (USDHHS, 2020). Understanding a
patient's health history and self-care practices can be a method by which primary care
providers can start to have open conversations that can improve patient-provider
communications about depression (Barnes et al., 2018; USDHHS, 2020).
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Barnes et al. (2018) suggested a person’s personal health history, chronic physical
conditions, and depression self-care practices were elements of the patient data that
should be reviewed and discussed by a health care provider among AA clients ages
eighteen and older. Also, AA would not initiate discussion about being depressed when
seeing their primary care provider because they did not think it was appropriate to do so
in primary care. Fear of not having a choice in making treatment decisions was another
reason given for not initiating a discussion with their provider regarding depression
( Barnes et al., 2018; Riley & Daniel, 2020).
Murphey and Hankerson (2017) emphasized among AA 24-79 years old, believed
the causes of depression are what influenced their decision regarding treatment for
depression. The writers examined the views of low-income participants and determined
there was an association between what people believed about the causes of depression.
The study stressed beliefs about the causes of depression fell into categories;
psychosocial, supernatural, and natural causes. The authors concluded a person's belief
regarding the cause of depression was associated with the type of treatment accepted and
whether the person would adhere to medical treatment.
Hays (2017) indicated the role of religion and social support is a substantial factor
in AA and a diagnosis of depression. Often AA does not choose to use the limited
resources that are available for mental health in their communities. Studies postulate that
AA believes depression is a personal weakness and that prayer when coupled with faith,
will be cured. These individuals will seek out a faith-based individual to help guide their
mental health, thus leading to a disproportionate number of AA refusing professional
psychological assistance as an option (Anthony et al., 2015; Hays, 2017). Mental health
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can be treated by a primary care provider in a primary care setting (National Alliance on
Mental Illness [NAMI], 2022). However, a small percentage of AA with depression is
treated in primary care (Jolly et al., 2016; Olfson et al., 2016).
Kato et al. (2018) proclaimed the percentage of respondents who were uninsured
and assessed for depression in the presence or absence of symptoms, was frequently
missed, resulting in no treatment. Pfoh et al. (2015) reported that low-income patients had
the lowest number of screenings for depression in primary care. Several studies
highlighted the dismal numbers of screenings for depression in primary care (Barnes et
al., 2019; Borja-Hart et al, 2013; Kato et al., 2018; Pfoh et al., 2015) the need to intensify
efforts in addressing screenings to advance the mental health needs to meet the USPSTF
recommendations is critical (Siu et al., 2016).
Randle et al. (2019) revealed in an article the routine implementation of
depression screening in primary care helped to overcome barriers to diagnosis and
treatment for depression resulting in a 41% increase in clients with co-morbidities being
diagnosed with depression and there was a net benefit to screening and treating
depression.
Surprisingly, the aforementioned studies did not mention the use of a structured
screening tool for depression such as the PHQ-9. The PHQ-9 is the self-administered
depression component of the Primary Care Evaluation of Mental Disorders (PRIME –
MD), a diagnostic instrument for common mental disorders with five modules developed
in the mid-1990s and was used by medical professionals (Kroenke et al., 2001). The
PRIME-MD, tool was designed to alert the provider to the presence and severity of
depression and the possibility of suicidal thoughts (Kroenke et al., 2001). The PHQ-9
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screening tool has evolved for medical providers to use for diagnosing depression. In
addition, the tool guides prescribing and measuring responses to treatment and recovery
(Malpass et al., 2016).
The literature revealed that PHQ-9 is cost-effective and significantly less
expensive than other screening tools (Jiao et al., 2017). This tool can guide the provider
to diagnose major depressive disorder (Levis et al., 2019) and is dependable and valid.
The PHQ-9 aligns with the APA, and DSM-V criteria for indicating major depressive
disorder. The PHQ-9 used in primary care by providers is one of the most widely selfreported questionnaires for depression screening. The primary care clinic where this
project took place utilized the PHQ-9 to help diagnose depression in clients presenting
with mental health issues although it was not a part of routine screening. However,
recently the clinic implemented depression screening with the PHQ-9 for all newly
admitted clients during their initial visit with a primary care provider.
In summary, AA adults with co-morbid depression commonly not diagnosed or
even screened for depression and can face an inferior quality of life. Many AA adults are
often reluctant to express their feelings or to discuss whether they are depressed. Studies
have shown clients with unrecognized depression see their providers more frequently and
consume greater health care resources (Bamgbade et al., 2020; Jolly et al., 2016). It is
also known that individuals diagnosed with depression are more likely to be uninsured.
Providers having the knowledge and awareness that AA is reluctant to express symptoms
of depression should be ready to raise the issue and initiate the discussion with their
clients. Open discussions between providers and clients are recommended to overcome
diagnostic and treatment barriers. The gaps and limitations in the literature underline the
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need for uninsured AA clients to have a screening and evaluation by the primary care
provider for depression in primary care. The USPSTF recommends improving depression
screening rates to meet the expectancy of the Healthy People 2030 (USDHHS, 2020).
The USDHHS Healthy People 2030 objectives are to increase depression
screenings in primary care settings. The PHQ-9 has proven to increase the detection of
depression when used in primary care settings (Siu et al., 2016). Recommendations for
treatment for AA clients found to be depressed should be adapted to meet the client's
needs, with the option to include medication and or medication and counseling. The
provider should consider the severity of a client's depression when making
recommendations for treating those who screen positive for depression. Care
coordination, social activities, and religious involvement could be part of the treatment
plan to improve health and depression outcomes.
The need for depression screening at the initial primary care visit was essential to
align with the recommendations of the USPSTF and USDHHS (2020). The Iowa Model
EBP framework guided the process to address the problem of the lack of screening clients
for depression in an urban primary care clinic that serves the underinsured and uninsured.
The clinic made depression screening a priority and initiated screenings with all new
clients during their initial primary care visit. The goal of the QI project was to evaluate
the effectiveness of the implementation of depression screening in the detection of
depression in the clinic's population, particularly the AA population. The results of the
evaluation provided the clinic with data needed to sustain the standards recommended by
the USPSTF and achieve the goals of Healthy People 2030 (USDHHS, 2020).
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Methods
Design
This QI pilot was designed to evaluate the effectiveness of the use of the
structured self -administered PHQ-9 with AA clients over three months, occurring
February 2022 to April 2022.
Setting
This project took place at a small nurse-managed clinic in an urban area that
provides primary care and specialty health services. The clinic serves approximately two
thousand people annually, 18 – 72 years old, all low-income, and 92% AA. The clinic
operates Tuesday – Friday from 9 am – 5 pm. The primary care providers are all
volunteers and are comprised of six providers, most are retired doctors and a family nurse
practitioner. The services provided include asthma and allergy, neurology, podiatry,
GYN, psychiatry, optometry, and chiropractic services. The clinic staff are two registered
nurses one being a (DNP) and two volunteer registered professional nurses, a
receptionist, and medical records person, the chief executive officer (CEO) is a women’s
health practitioner, and the chief financial officer (CFO), and an assistant administrator.
All the staff both volunteers and employed are White and AA, males, and females.
Sample
A convenience sample of new AA clients registered in the clinic participated in
this project. There were 20 AA out of twenty-four new clients 18 – 65 years old who met
the criteria for this QI pilot project. The inclusion criteria were adults 18-65 years of age,
English speaking, and must be new patients to the clinic. The exclusion criteria were
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adults older than 65 years of age, non-English speaking, and established patients of the
clinic for more than 30 days. The desired sample size was twenty or more.
Procedures
Preliminary staff meetings for this project took place with the CEO, the
administrative assistant, and the clinic staff comprised of the NP, two RNs, the medical
records clerk, the receptionist, the medical director, and the psychiatrist. The criteria for
client participation in the screenings, the workflow for the encounter, documentation for
participation, and the collection of the data were discussed. The clinic staff collectively
made the decision to screen all new clients for depression. The clinic CEO and
management staff designed a detailed plan for implementing the screening service put in
effect in January 2022. Notices of the new depression screening protocol and flyers
posted in the receptionist area, and throughout the clinic. The registrar notified new
clients at the time of registration that the clinic was conducting depression screenings
with all new clients. New clients were given a registration packet containing a consent
form and the PHQ-9 questionnaire. The registrar provided instructions on how to
complete the questionnaire. Additionally, during the nursing assessment the nurse ensures
the clients did not have questions regarding the PHQ-9 form.
Questions the clients may have regarding depression screening the nurse directed
them to discuss their question with the primary care provider. The client chart including
the screen tool was available to the provider. During the primary care visit the provider
tallied the client's scores in accordance with the scoring range provided by the PHQ-9
tool, reviewed the results with the client during the physical examination, and made
referrals as needed. The clinic protocol was for clients with scores of ten or greater to
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receive further evaluation which may include referrals to the nurse practitioner, social
worker, counselor, or psychiatrist. Clients answering yes to having thoughts of self-harm
or being better off dead; or with a total score in the range of 15 – 27 received an
evaluated by the psychiatric nurse practitioner or the psychiatrist following the clinic
safety plan and behavioral health protocol.
Data Collection and Analysis
In collaboration with the psychiatrist and input from the Advanced Practice
Nurse (APRN-BC), the investigator developed a depression screening spreadsheet in
Microsoft Excel to collect the numerical data from completed PHQ-9 questionnaires.
Prior to completing the spreadsheet, the clients were de-identified to protect their
information. The data collected and entered on the spreadsheet monthly was from the
completed questionnaire including gender, race, age, date of screening, questions from on
the PHQ-9 with the client's corresponding response, a total score of the depression
screening, if the client was referred for further evaluation for diagnosis with depression,
the level of depression, and treatment or resources provided.
The data analysis was performed using Microsoft Excel. A descriptive statistical
analysis evaluated the depression screening value and calculate the outcomes of the
number of clients identified with depressive symptoms, diagnosed with depression, and
who received treatment. A retrospective chart review occurred from February 2022 to
April 2022 to evaluate the effectiveness of the screenings with AA. The clinic and
Institutional Review Board (IRB) approval were obtained prior to data collection and
analysis.
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Approval Process
Approvals from the student's doctoral committee of graduate studies, the
organization, and the university IRB were given There are no known ethical
considerations.
Results
There was a total number (N=24) of new clients screened for depression using
the PHQ-9 screening questionnaire at their initial primary care visit from February 2022
– April 2022. Of the total 16.6% (n = 4) were Whites and 83.3% (n = 20) were AA. Sixty
– seven percent (n = 16 ) was AA females, 17% (n = 4) AA males, 8% (n = 2) White
females, and White males (n = 2) (see Appendix A). Of the AA clients 25% (n = 5)
scored 10 –14 indicating moderate depression; 5% (n = 1) scored six points signaling
mild depression; 70% (n = 14) scored zero suggesting none to minimally depressed.
There were (n = 4) Whites and two of the four had a score of 10 – 20 and diagnosed and
treated for depression. The largest group receiving treatment was AA females 72 % (n =
5). AA males were 16.66 % (n = 4) of the clients screened, in which all had scores of zero
and no treatment needed (see Appendix B). AA females 20 – 29-year-olds were the
largest group treated at 43% (n = 3). The 50 -59-year-olds were comprised of AA females
29% (n = 2) and WM 14% ( n = 1). Of the 30 – 39-year-olds, WF 14% (n = 1) received
treatment (Appendix). For clients 40 - 49 or 60 -65 years old for PHQ-9 scores of ten or
less no treatment needed (see Appendix C). Seven clients (n = 7) received treatment, i.e.,
counseling, medication, or both. The primary care provider prescribed medication for
57% (n = 4) on the day of the initial visit, with a follow-up visit to see the psychiatrist for
43% (n = 3). Statistically, the total number of clients with PHQ-9 scores warranting
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treatment was (N =7) for scores ten≥ ranging from 10 - 21, with a mean of 13, a median
of 11.00, and the mode of treatment was counseling.
Discussion
The clinic-initiated depression screening using the PHQ-9 on all new clients
during their initial primary visit to see a health care provider. This QI pilot project
evaluated the effectiveness of the implementation of depression screening to detect
symptoms of depression and to initiate early intervention with AA clients who screened
positive with scores of 10 ≥. A total of (N = 24) new clients were screened for depression
from February 2022 – April 2022. The provider informed the client that counseling,
social services, and psychiatry were available for depression. A nurse or the primary care
provider assisted the client with the questionnaire if needed. All 100% (N = 24) received
information regarding depression. Those needing further evaluation or medications
started medication immediately. The psychiatric nurse practitioner initiated a call to the
client within a week after their initial visit and diagnosis, with all the clients’ accepting
referrals for counseling.
The study question whether the implementation of depression screening utilizing
the PHQ-9 in primary care with African American adults, 18 years – 65 years old, who
screened positive for depression would accept treatment during the 12 weeks. The
purpose of this QI pilot project was to examine the results of implementing depression
screening (PHQ-9) in a primary care setting for uninsured adults for detection, diagnosis,
and treatment of depression in AA client. The primary care provider prescribed antidepressive medication for 57% (n = 4) with a follow- up visit to see the psychiatrist.
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The limitations of this QI pilot project were the self-administration of the PHQ-9
screening tool due to literacy issues in the underserved population which required time to
explain or interpret questions. The limited knowledge and experience of the nursing staff
and primary care providers using the PHQ-9 screening tool. The method used for
monitoring registration, scheduling and tracking referrals, conducting chart reviews, and
reviewing the electronic health records could be prohibitive with larger sample sizes.
The recommendation for future studies is to continue to review the effectiveness
of depression screening utilizing the PHQ-9 for a more extended period in the primary
care setting. PHQ-9 is tool recommended for screening to cost, and effectiveness and can
detect and increase in the number of clients reporting depressive symptoms in response to
the screenings. Studies that examine the effectiveness of early detection and treatment of
depression in uninsured and underinsured AA populations must continue. Training the
staff in the primary care setting on the PHQ-9 screening tool, to assist the clients when
needed.
Conclusion
The lack of insurance creates a barrier to health and mental health services
resulting in AA receiving poorer care or no care at all. The burden of mental disorders is
associated with a high prevalence of disability with unmet needs not treated. Issues such
as cost, no insurance, beliefs, and structural barriers are significant impediments to
treatment (Walker et al., 2015). Often underinsured or uninsured individuals will not seek
treatment for depression; therefore, when an individual seeks medical treatment in a
primary care setting, the providers must conduct a physical and mental health assessment
(Meyers et al., 2014). Recognizing depression in a primary care setting, especially in a
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patient with co-morbid conditions, is difficult (Ferenchick et al., 2019; Hooker et al.,
2019; Park & Zarate, 2019; Richardson & Brahmbhatt, 2021).
Incorporating depression screening with the initial primary care visit seems to be
beneficial. During the three months of evaluating the implementation of depression
screening, 100% of the new clients participated and completed the PHQ-9 questionnaire.
The results from the data illustrated that using the PHQ-9 screening tool was instrumental
in the early detection and intervention of depression in the uninsured and underinsured
AA population.

EVALUATING DEPRESSION SCREENING

19

References
American Psychological Association [APA]. (2020). Patient healthcare questionnaire.
PHQ-9 and PHQ-2. Construct Depressive symptoms.
https://www.apa.org/pi/about/publications/caregivers/practicesettings/assessment/tools/patient-health
Anthony, J.S., Morris, E., Collins, C.W., Watson, A., Williams, J.E., Ferguson, B., Ruhlman,
D.L. (2016). Equipping aa clergy to recognize depression. Journal of Christian Nursing.
33(4) p 230 – 237.
https://journals.lww.com/journalofchristiannursing/Abstract/2016/10000/Equipping_Afri
can_American_Clergy_to_Recognize.12.aspx

Bailey, R.K., Mokonogho, J., & Kumar, A. (2019). Racial and ethnic differences in
depression; current perspectives. Neuropsychiatric Disease and Treatment,
19(15), 603-609; https://doi.org/10.2147/NDT.S128584
Bamgbade, B., Barner, J., Ford, K.H., Brown, C.M., Lawson, W.B. & Burdine, K.
(2020). Willingness to Seek Help for Depression in Young African American
Adults: Study Protocol. JMIR research protocols, 9(2), e16267.
https://doi.org/10.21961/16267
Barnes, P. A., Mayo-Gamble, T. L., Harris, D., & Townsend, D. (2018). Correlation
between personal health history and depression self-care practices and depression
screening among African Americans with chronic conditions. Preventing Chronic
Disease, v 15. E149 https://doi.org/10.5888/pcd15.170581.
Borja-Hart, N., Wooten, A., & Debile, T. (2013). Depression screening in uninsured
patients in a primary care setting. Mental Health Clinician, 3(4), 198–201.
https://doi.org/10.9740/mhc.n172523.

EVALUATING DEPRESSION SCREENING

20

Center for Disease Control and Prevention [CDC]. (2021). Summary Health Statistics:
National Health Interview Survey: 2018. Table A-7.
https://www.cdc.gov/nchs/nhis/shs/tables.htm
Cobb, S., Bazargan, M., Sandoval, J. C., Wisseh, C., Evans, M. C., & Assari, S. (2020).
Depression treatment status of economically disadvantaged African American
older adults. Brain Science, 10(3). https://doi.org/doi:10.3390/brainsci10030154.
Feldman, R., Schreiber, S., Pick, C.G., Been, E. (2020). Gait, balance and posture in
major mental illness: depression, anxiety, and schizophrenia. Austin Medical
Sciences, Austin Publishing Group, 5(1), 1039.
https://austinpublishinggroup.com/medical-sciences/fulltext/ams-v5-id1039.pdf
Ferenchick, E.K., Ramanuj, P., Pincus, H.A. (2019). Depression in primary care: part 1screening & diagnosis. https://doi.org/10.1136/bmj.1794.
Haftgofi, N., Favat, B., Verdon, F., Vaucher, P., Bischoff, T., Burnand, B., & Herzig, L.
(2010). Patients presenting with somatic complaints in general practice:
depression, anxiety and somatoform disorders are frequent and associated with
psychosocial stressors. BMC Family Practice, 11(67).
https://pubmed.ncbi.nlm.nih.gov/20843358/. doi.10.1186/1471-2296-11-67.
Hays, K. (2017). A risk typology for depression in African Americans. Issues in Mental
Health Nursing, 38(10), 812–821.
https://doi.org/10.1080/0162840.2017.1342727.
Hooker, K, Phibbs, S., Irvin, V., Mendes-Luck, C., Doan, L., Li, T., Turner, S., & Choun,
S. (2019). Depression among older adults in the united states by disaggregated
race and ethnicity. The Gerontological Society of America, 59(5) 886-891.

EVALUATING DEPRESSION SCREENING

21

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729206/
Iowa Model Collaborative, Buckwalter, K.C., Cullen, L., Hanrahan, K., Kleiber, C.,
McCarthy, A.M., Rakel, B., Steelman, V., Tripp-Reiner, T., & Tucker, S. (2017).
Iowa Model of Evidence-Based Practice: Revisions and Validation. Worldviews
evidence-based nursing, 14(3), 175-182. https://doi.org/10.1111/wvn.12223
Jiao, B., Rosen, Z., Bellanger, M., Belkin, G., & Muenning, P. (2017). The cost effectiveness of PHQ screening and collaborative care for depression in New
York, PLoS One, 12(8).
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578679/pdf/pone.0184210.pdf
Jolly, J. B., Fluet, N.R., Reis, M.D., Stern, C.H., Thompson, A.W., & Jolly, A. (2016).
Review of behavior health integration in primary care at Baylor Scott and White
healthcare, central region. Baylor University Medical Center Proceedings. 29(2).
131-136. Doi:10.1080/08998280.2016.11929388.
Kato, E., Borsky, A., Zuvekas, S., Soni, A., & Ngo-Metzger, Q. (2018). Missed
opportunities for depression screening and treatment in the United States. Journal
Board of Family Medicine, 31(3), 389–397. DOI:
https://doi.org/10.3122/jabfm.2018.03.170406.
King, T.E., Wheeler, M.B., Bindman, A. B., Fernandez, A., Grumbach, K., Schillinger,
D., & Villela, T. J. (2016). Medical management of vulnerable and underserved
patients: principles, practice, and populations (2nd ed.). McGraw-Hill Education /
Medical.

EVALUATING DEPRESSION SCREENING

22

Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001). The PHQ-9. Validity of a brief
depression severity measure. Journal of General Internal Medicine, 16(9), 606 613. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1495268/
Levis, B., Benedetti, A., &Thombs, B. D. (2019). Depression screening data
(DEPRESSD) Collaboration. Accuracy of patient health questionnaire-9 (phq-9),
for screening to detect major depression: individual participant data metaanalysis. APA PsycNet. BMJ, 365(11476).
https://www.bmj.com/content/365/bmj.l1476.short
Malpass, A., Dowrick, C., Gilbody, S., Robinson, J., Wiles, N., Duffy, L., & Lewis, G.
(2016). Usefulness of phq-9 in primary care to determine meaningful symptoms
of low mood: a quality study. British Journal General Practice, 66(643), e78 –
e84. DOI.10.3399/bjgp16x683473.
Meyers, M., Grob, C., & Binienda, J. (2014). Depression screening and treatment in
uninsured urban patients. Journal of the American Board of Family Medicine.
DOI: https://doi.org/10.3122/jabfm.2014.04.130254.
Miranda, J., Bromley, E., Izquierdo, A., Jones, F., & Wells, K. (2017). Surviving
depression clinical qualitative analysis of long-term survival for ethnically
diverse, depressed patients. The Journal of Nervous and Mental Disease, 205(8),
589–599. https://doi.org/10.1097/NMD.0000000000000632.
Murphy, E., & Hankerson, S. (2017). Beliefs about causes of major depression: Clinical
and treatment correlates among African Americans in an urban community.
Journal of Clinical Psychology, 74(4), 594–607.
https://doi.org/10.1002/jclp.22523

EVALUATING DEPRESSION SCREENING

23

National Alliance on Mental Illness [NAMI]. (2022). Treatment Settings.
https://www.nami.org/About-Mental-Illness/Treatments/Treatment-Settings
National Institute of Mental Health [NIMH]. (2021). Chronic illness and mental health:
recognizing and treating depression.
https//www.nimh.nih.gov/health/publications/chronic-illness-mental health
National Institute of Mental Health [NIMH]. (2022). Major Depression.
https://www.nimh.nih.gov/health/statistics/major-depression
Office of Disease Prevention and Health Promotion. (n.d.). Increase the proportion
of adults with depression who get treatment -mhmd-05. Healthy People
2030. U.S. Department of Health and Human Services.
https://health.gov/healthypeople/objectives-and-data/browse-objectives/mentalhealth-and-mental-disorders/increase-proportion-adults-depression-who-gettreatment-mhmd-05
Office of Disease Prevention and Health Promotion. (n.d.). Social determinants of
health. Healthy People 2030. U.S. Department of Health and Human
Services. https://health.gov/healthypeople/priority-areas/social-determinantshealth#:
Olfson, M., Blanco, C., & Marcus, S.C. (2016). Treatment of adult depression in the
United States. Journal of American Medical Association Internal
Medicine,176(10), 1482 -1491. Doi:10.1001/jamainternmed.2016.5077.
Park, L.T.& Zarate, C.A. (2019). Depression in the primary care setting. The New
England Journal of Medicine,380(6) 559-568.
http://www.ncbi.nlmlnih.gov/pmc/articles/PMC6727961.

EVALUATING DEPRESSION SCREENING

24

Pfoh, E.R., Mojtabai, R., Bailey, J., & Weiner, J.P. (2015). Conformance to depression
process measures of Medicare part B beneficiaries in primary care settings.
Journal of the American Geriatric’s Society, 63(7), 1338-1345.
Doi:10.1111.jgs.13483
Randle, A. C., Spurlock, A. L., & Kelley, S. (2019). Depression screening among African
American adults in the primary care setting. Journal of Psychosocial Nursing and
Mental Health Services, 57(10), 18–23.
https://doi.org/doi.org/10.3928/02793695-20190610-01
Richardson, L. & Brahmbhatt, A. (2021) Depression in primary care. Journal for Nurse
Practitioners, 17(1), 37 -43. https://doi.org/10.10161/j.nurpra.2020.09.002.
Riley, M. & Daniel-Hill, J., (2020). What factors lead to the underdiagnosis of depression
among african americans. Evidence -Based Practice, 23(4), 41-42.
Doi.10.1097/EBP.0000000000000619.
Siu, A.L., U.S. Preventative Services Task Force (USPSTF), Bibbins-Domingo, K.,
Grossman, D.C., Baumann, L.C., Davidson, K. W., Ebell, M., Garcia, F.A.,
Gillman, M., Herzstein, J., Kemper, A.R., Krist, A. H., Kurth, A.E., Owens, D.K.,
Phillips, W.R., Phipps, M.G. & Pignone, M. P. (2016). Screening for depression
in adults US Preventive Services Task Force recommendation statement. JAMA.
315(4). 380-387. Doi:10.1001/jama.2015.18392
St. Louis City - MO. Gov. (n.d.). Retrieved August 2, 2021, from https://www.stlouismo.gov/government/departments/mayor/initiatives/resilience/equity/opportunity/h
ealth-safety/health-insurance.cfm.
US Census Bureau. (2020). American Community Survey Data Releases.

EVALUATING DEPRESSION SCREENING

25

https://census.gov/programs-surveys/acs/news/data-releases.html
US Department of Health and Human Services. [USDHHS]. (2020). Healthy People
2030, mental health, and mental disorders.
https://health.gov/healthypeople/objectives-and-data/browse-objectives/mentalhealth-and-mental-disorders/increase-proportion-adults-depression-who-gettreatment-mhmd-05
US Department of Health and Human Services. [USDHHS]. (2021) Office of Minority
Health . profile black/african americans.
https://minorityhealth.hhs.gov/omh/browse.aspx?lvl=3&lvlid=61#:~:text=Finally
%2C%2010.1%20percent%20of%20non,and%2074.0%20years%20for%20men.
Walker, E.R., Cummings, J.R., Hockenberry, J.M., & Druss, B.G. (2015). Insurance
status, use of mental health services, and unmet need for mental health care in the
United States. Psychiatric Service, 66(6), 578-584.
Doi:10.1176/appi.ps.201400248
World Health Organization (2017). Depression and other common mental disorders:
global health estimates.
https://apps.who.int/iris/bitstream/handle/10665/254610/WHO-MSD-MER2017.2-eng.pdf.
World Health Organization (2021). Depression. https://www.who.int/news-room/factsheets/detail/depression.

EVALUATING DEPRESSION SCREENING

26

Appendix A
Figure 1
Demographics of clients screened using the PHQ-9

Demographics (N=24)

(n=2)
8%
(n=2)
8%

(n=4)
17%

(n=16)
67%

AA Female

AA Male

White Female

White Male

Note: This represents the percentage of new clients screened from February
2022 - April 2022, with the PHQ-9 questionnaire at the time of the initial
visit (N=24).
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Appendix B
Table 1
PHQ- 9 results
Race
AA
AA
AA
Whites
Treatment Group
Race & Gender
AA F
AAM
WF& WM

Number
5
1
14

Scores
10 -14
6
0

4

10 -20

Screened 10 ≥ = 7

29%

5
0
2

71%
0
29%

3
1
3

43%
14%
43%

Primary care provider
initiated medication during the
initial visit

4

57%

Follow-up visit with psychiatrist
Counseling

3
7

43%
100%

Age Groups
20 – 29
30 – 39
50 – 59
Treatment & Referrals

Note: Statistically, the total number of clients with PHQ-9 scores warranting treatment
was N =7 or 29%.The PHQ-9 scores warranting treatment for 10≥ ranged from 10 - 21,
with a mean 13, a median of 11.00 and the mode of treatment was counseling with a SD
of 5.
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Figure 3

Appendix C

Note: This represents the treatment group by numbers who warranted treatment
scoring 10 ≥ on PHQ-9 by race, gender, and age. There were no AA males in the
treatment group.

28

